Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

872 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular profiling of clinical tissue specimens: feasibility and applications.
Emmert-Buck MR, Strausberg RL, Krizman DB, Bonaldo MF, Bonner RF, Bostwick DG, Brown MR, Buetow KH, Chuaqui RF, Cole KA, Duray PH, Englert CR, Gillespie JW, Greenhut S, Grouse L, Hillier LW, Katz KS, Klausner RD, Kuznetzov V, Lash AE, Lennon G, Linehan WM, Liotta LA, Marra MA, Munson PJ, Ornstein DK, Prabhu VV, Prange C, Schuler GD, Soares MB, Tolstoshev CM, Vocke CD, Waterston RH. Emmert-Buck MR, et al. Among authors: brown mr. Am J Pathol. 2000 Apr;156(4):1109-15. doi: 10.1016/S0002-9440(10)64979-6. Am J Pathol. 2000. PMID: 10751334 Free PMC article. Review. No abstract available.
Angiogenesis in ovarian cancer.
Brown MR, Blanchette JO, Kohn EC. Brown MR, et al. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000 Dec;14(6):901-18. doi: 10.1053/beog.2000.0134. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000. PMID: 11141340 Review.
Molecular profiling of clinical tissues specimens: feasibility and applications.
Emmert-Buck MR, Strausberg RL, Krizman DB, Bonaldo MF, Bonner RF, Bostwick DG, Brown MR, Buetow KH, Chuaqui RF, Cole KA, Duray PH, Englert CR, Gillespie JW, Greenhut S, Grouse L, Hillier LW, Katz KS, Klausner RD, Kuznetzov V, Lash AE, Lennon G, Linehan WM, Liotta LA, Marra MA, Munson PJ, Ornstein DK, Prabhu VV, Prang C, Schuler GD, Soares MB, Tolstoshev CM, Vocke CD, Waterston RH. Emmert-Buck MR, et al. Among authors: brown mr. J Mol Diagn. 2000 May;2(2):60-6. doi: 10.1016/s1525-1578(10)60617-4. J Mol Diagn. 2000. PMID: 11272889 Free PMC article. Review. No abstract available.
EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignancies.
O'Mahony D, Morris JC, Stetler-Stevenson M, Matthews H, Brown MR, Fleisher T, Pittaluga S, Raffeld M, Albert PS, Reitsma D, Kaucic K, Hammershaimb L, Waldmann TA, Janik JE. O'Mahony D, et al. Among authors: brown mr. Clin Cancer Res. 2009 Apr 1;15(7):2514-22. doi: 10.1158/1078-0432.CCR-08-1254. Epub 2009 Mar 17. Clin Cancer Res. 2009. PMID: 19293260 Free PMC article. Clinical Trial.
Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy.
Sportès C, Babb RR, Krumlauf MC, Hakim FT, Steinberg SM, Chow CK, Brown MR, Fleisher TA, Noel P, Maric I, Stetler-Stevenson M, Engel J, Buffet R, Morre M, Amato RJ, Pecora A, Mackall CL, Gress RE. Sportès C, et al. Among authors: brown mr. Clin Cancer Res. 2010 Jan 15;16(2):727-35. doi: 10.1158/1078-0432.CCR-09-1303. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068111 Free PMC article. Clinical Trial.
872 results